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Novel variation and de novo mutation rates in
population-wide de novo assembled Danish trios
Søren Besenbacher1,*, Siyang Liu2,3,*, Jose´ M.G. Izarzugaza4,*, Jakob Grove1,5,6,7, Kirstine Belling4,
Jette Bork-Jensen8, Shujia Huang2,9, Thomas D. Als5,6,7, Shengting Li2,5,6,7, Rachita Yadav4,
Arcadio Rubio-Garcı´a4, Francesco Lescai5,6,7, Ditte Demontis5,6,7, Junhua Rao2, Weijian Ye2, Thomas Mailund1,5,
Rune M. Friborg1,5, Christian N.S. Pedersen1, Ruiqi Xu2, Jihua Sun2, Hao Liu2, Ou Wang2, Xiaofang Cheng2,
David Flores4, Emil Rydza4, Kristoffer Rapacki4, John Damm Sørensen4, Piotr Chmura4, David Westergaard4,
Piotr Dworzynski4, Thorkild I.A. Sørensen8,10, Ole Lund4, Torben Hansen8,11, Xun Xu2, Ning Li2, Lars Bolund5,7,
Oluf Pedersen8, Hans Eiberg12, Anders Krogh3,13, Anders D. Børglum5,6,7, Søren Brunak4, Karsten Kristiansen3,
Mikkel H. Schierup1,5, Jun Wang2,3,5, Ramneek Gupta4, Palle Villesen1,5 & Simon Rasmussen4
Building a population-speciﬁc catalogue of single nucleotide variants (SNVs), indels and
structural variants (SVs) with frequencies, termed a national pan-genome, is critical for
further advancing clinical and public health genetics in large cohorts. Here we report a Danish
pan-genome obtained from sequencing 10 trios to high depth (50 ). We report 536k novel
SNVs and 283k novel short indels from mapping approaches and develop a population-wide
de novo assembly approach to identify 132k novel indels larger than 10 nucleotides with low
false discovery rates. We identify a higher proportion of indels and SVs than previous efforts
showing the merits of high coverage and de novo assembly approaches. In addition, we use
trio information to identify de novo mutations and use a probabilistic method to provide
direct estimates of 1.27e8 and 1.5e9 per nucleotide per generation for SNVs and indels,
respectively.
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T
he ability to study human genomes and to discover a
complete set of variations between individual genomes has
increased tremendously with advances in sequencing
throughput and analysis capabilities. Considerable efforts have
led to categorization of millions of single nucleotide variants
(SNVs), small insertions and deletions (indels) and larger
structural variants (SVs) between human individuals and
populations1–5. A population-speciﬁc inventory of all detectable
variation, a ‘national pan-genome’, has importance for clinical
and public health genetics, for example, in facilitating imputation
of rare variants in genome-wide association studies and low-pass
sequencing studies6,7 and in addressing missing heritability
due to an incomplete or inadequate human reference genome.
However, the ability to phase and impute complex variants and
haplotype regions relies on accurate identiﬁcation of these in the
reference data. There is a clear trade-off between using available
resources for sequencing a few individuals at high quality and
sequencing depth or many individuals at lower coverage. Most
studies to date have been based mainly on low (4–5 )1 or
intermediate (10–30 )7–9 sequencing depth with a few notable
exceptions6,10. Identiﬁcation of indels and SVs from short
reads are challenging and most methods are based on
alignment of reads to reference genomes and identifying SVs
from irregularities in paired end mapping or local assembly11–14.
However, read mapping to regions containing large and complex
variants remain troublesome and especially insertions are difﬁcult
because a large fraction of the read is novel sequence that is not
represented in the reference genome. Higher depth provides more
accurate genotyping of variants and long-range libraries allow
better characterization of indels and SVs, and a good basis for
complementing approaches with genome-wide array scans
cataloguing population-speciﬁc variation.
High depth and trio information are also needed for estimating
de novo mutation events. Characterizing de novo mutations are
fundamental for investigating the causes of genetic diseases15 and
determining their rate is important for timing events in human
evolution16. Recent studies have used whole-genome sequencing
of trios to directly estimate the SNV de novo mutation rate. Given
the rarity of the de novo events, calculating such an estimate is not
a trivial task and there are still some uncertainties about the
actual rate and the strength of the paternal age effect17. Because
de novo indels are even rarer than de novo point mutations and
moreover harder to detect, most studies of de novo events have
not included these. Currently the only direct measure of indel de
novo mutation rate comes from a study of a single trio18.
Here we present a variant catalogue established through
sequencing 10 trios to high depth (50 ) using libraries with
insert sizes from 180 to 800 bp. High quality variants were called
and false discovery rate (FDR) was determined to be low in
validation experiments. We report 8.37 million bi-allelic SNVs
and 1.24 million bi-allelic short indels from alignment-based
methods of which 6.4% and 22.8% were novel, respectively. We
use the trio structure of the data to identify de novo mutations
and develop a probabilistic method to determine de novo
mutation rates for SNVs and indels. For indels we provide the,
to date, most accurate de novo mutation rate of 1.5e 9 per
nucleotide per generation. For SNVs, we estimate a mutation rate
of 1.27e 8 per nucleotide per generation, which is slightly
higher compared with previous studies. In addition, as de novo
assembly previously has shown promise for detection of SVs in
single human genomes19,20, we expand this approach to be used
at population level and identify 53.2k and 78.5k novel deletions
and insertions (410 bp), respectively, with a low FDR. Medium-
sized (20–300 bp) insertions display a high rate of novelty (49.0k
of 53.1k are novel; 92.2%) and a low overlap with alignment-
based methods (o10%). This is likely due to ascertainment bias
when using traditional alignment-based methods for detection of
insertions and underlines the importance of de novo assembly-
based techniques for discovering variation.
Results
Discovering novel SNVs and short indel variation. Ten father–
mother–offspring Danish trios from the Copenhagen Family
Bank21,22 were sequenced to an average of 52 , except for four
individuals sequenced to 19 (Supplementary Data 1). SNVs
and short indels (o50 bp) were called using the Genome Analysis
Toolkit (GATK)23. Our analyses lead to the detection of 8.37
million bi-allelic SNVs and 1.24 million short bi-allelic indels.
The concordance between the sequencing SNV calls and chip
genotyping data is 99.8%, which is higher than the 98.9%
achieved by intermediate range depth sequencing in a recent
study by Boomsma et al.8 (Supplementary Table 1). We observed
536k SNVs (6.4%) and 283k indels (22.8%) not previously
reported and as expected novel variants were generally rare in the
population (Fig. 1a,b, Supplementary Tables 2–3, Supplementary
Fig. 1). The size distribution of indels shows enrichment of 2 and
4 bp indels outside exons, and that 44% of indels in exons are in-
frame (Fig. 1c). Due to the high number of novel indels and that
indels in repeat regions are hard to accurately call, we classiﬁed
the indels based on their primary sequence context into
homopolymer runs (HRs) and tandem repeats (TRs)4. In total
40.9% of the indels were associated with a canonical HR or TR
and an additional 19.3% were associated with non-canonical HR
or TR sites. The FDR determined from Sanger sequencing was
very low for SNVs (2%), however, indels had a higher overall FDR
(15%). The high FDR was due to indels in repeat regions (27%
FDR) compared with non-repeat regions (0% FDR) (Table 1 and
Supplementary Data 2). We estimated the number of loss of
function (LOF) mutations in consensus coding sequences24–26 to
be in the range 83–117 per individual (average 111.8; Fig. 1d) and
individuals were homozygous for 18–33 of these, which is in line
with previous ﬁndings7,27. LOF mutations were generally rare
with 46% being private to the individuals, suggesting strong
purifying selection. Likewise, in-frame indels show evidence of
purifying selection (Supplementary Fig. 2). When subjected to
experimental validation (Table 1), we determined a FDR of 0 for
LOF SNVs (0/25) and 0.13 for LOF indels (2/15). Both of the
invalidated indels were located in HRs.
Calling de novo mutations. We identiﬁed de novo variants by
identifying new variants in the offspring that are not present in
either of the parents. After applying conservative ﬁlters on the
quality of the variants and on the genotype quality of the three
members of the trio (see methods), we had 730 candidate de novo
point mutations. Looking at the fraction of the reads in the
proband that carry the alternative allele (the allele balance),
reveals a bimodal distribution (Fig. 2a) that apart from the
expected mode at 50% also has a mode B18%. Since 98% of
SNVs with similar quality show an allele balance between 30 and
70% (Supplementary Fig. 3), we only consider the 508 candidate
mutations that fall in this range as being genuine de novo
germline mutations (applying the same 30% allele balance cutoff
as in Kong et al.9 and Neale et al.28). We believe that the
remaining 222 variants are either somatic variants with low allele
balance (only present in a fraction of the sequenced blood cells)
or sequencing artifacts. The true number of somatic variants in
these individuals is expected to be much higher since recent
somatic mutations are unlikely to be detected being present only
in a few cells and therefore too infrequent to pass the conservative
genotype quality ﬁlters. We have called short indel (o40 bp)
variants using the same approach and observe 70 germline
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variants and 54 putative somatic variants. Sanger sequencing
validation shows a low FDR for SNVs (4.1%, 1/24), whereas de
novo indel validation was made difﬁcult by de novo indels mostly
occurring in highly repetitive DNA (estimated FDR 10.5%, 2/19,
Table 1 and Supplementary Data 3).
Estimation of mutation rates for SNVs and indels. We
employed a novel probabilistic approach to estimate the effective
number of genomic positions where we would be able to call de
novo mutations (see methods). We ﬁnd an average germline
mutation rate of 1.27e 8 (95% CI of 1.16e 8 to 1.38e 8) per
generation corresponding toB73 expected de novo SNVs in each
newborn. The inferred mutation rate in offspring is signiﬁcantly
positively correlated with the age of the father (Fig. 2c). The
estimated effect of the father’s age is 3.88e 10 extra mutations
per nucleotide per year corresponding to approximately two extra
autosomal mutations per year, which is the same effect as was
measured in a large Icelandic study9. The estimate of the
mutation rate per generation depends a lot on the average age of
the fathers, which in our study is 28.4 years. Our rate estimate is
higher (but within the 95% signiﬁcance threshold) than reported
in the largest similar study of mutation rate (1.2e 8, average
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Figure 1 | Allele frequencies and loss of function (LOF) mutations. (a) Derived allele frequencies of bi-allelic known (n¼6.69M, blue) and novel
(n¼415k, orange) SNVs with genotype information in all 20 parents. Fixed variants are excluded. (b) Folded minor allele frequencies of known deletions
(n¼ 510k, solid blue), known insertions (n¼ 383k, dashed turquoise), novel deletions (n¼ 136k, solid red) and novel insertions (n¼ 126k, dashed orange)
with regard to the reference genome. Only bi-allelic and non-ﬁxed sites with genotype information in the 20 parents are included (for derived allele
frequencies, see Supplementary Fig. 1). (c) Size distribution of bi-allelic and non-ﬁxed indels (n¼ 1.19M) and indels in coding regions only (n¼ 1392, insert),
legend as in b, for insert coding indels (purple) and non-coding (green). (d) Estimated number of LOF variants for each parent (n¼ 20), in total 10.6% of
the mutations was in olfactory genes and 4.1% in zinc ﬁnger proteins. Stop gains (magenta), splice donor (blue), splice acceptor (turquoise) and indel
frameshift (orange).
Table 1 | Sanger validation of SNVs, short indels and de novo
variants.
Variant class FDR Sites
GATK-SNVs
Overall 0.02 46
Novel 0.05 21
Loss of function 0.00 25
GATK-indels
Overall 0.15 26
Repeat 0.27 15
Non-repeat 0.00 11
Novel 0.18 11
Loss of function 0.13 15
De novo variants
SNVs 0.04 24
Indels 0.11 19
FDR, false discovery rate; GATK, Genome Analysis Toolkit; SNV, single nucleotide variation.
Sanger sequencing experiments were used to assay the FDR for 21 novel, 25 loss of function and
24 de novo SNVs. For indels a total of 11 novel, 15 loss of function and 19 de novo indels were
assayed.
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age of fathers: 29.7)9 and signiﬁcantly larger than another
study with corresponding sample size (1e 8, average age of
fathers: 33.6)29.
As expected, we ﬁnd no correlation between the age of the
parents (at the offspring’s birth) and the number of somatic de
novo mutations. Likewise we did not ﬁnd any correlation between
the offspring age and the number of putative somatic variants
(Supplementary Fig. 4). We ﬁnd the mutational pattern to be very
similar for germline mutations and putative somatic mutations,
with a transition/transversion ratioB2 for non-CpG sites and an
extremely high transition rate for CpG sites (Fig. 2b). Of the 508
germline de novo mutations, 18 (3.5%) are already present in
database of single nucleotide polymorphisms (dbSNP). Of these
18 mutations, 50% are transitions in CpG sites compared with
only 19% of the 490 mutations not in dbSNP, supporting that the
overlap is due to recurrent mutations. We estimate the mutation
rate of short germline indels to be 1.5e 9 (95% CI of 1.2e 9 to
1.9e 9) per nucleotide per generation, which corresponds toB9
autosomal de novo indels in each newborn. This is consistent with
the results of a study that analyzed whole-genome data from a
single trio and reached a rate estimate of 1.0e 9 (95% CI of
2.35e 10 to 2.75e 9)18 but somewhat higher than an estimate
based on the sequencing of Mendelian disease genes (0.78e 9)30.
We observe approximately eight times more point mutations
than indels, which is the same ratio as has been estimated
based on whole-genome alignment of the human and mouse
genomes31. The correlation between paternal age and the rate of
germline indels (Fig. 2g) is not signiﬁcant, perhaps not surprising
given the low number of events we observe in each family. The
length distribution of the de novo indels shows a tendency for a
higher deletion rate both for germline and somatic indels
(Fig. 2e,f).
De novo assembly of 10 human trios. Preliminary efforts have
revealed how de novo assembly strategies can be employed for
detecting complex human variation19,20, and here we extend it to
be used in a population scenario. Using SoapDenovo2 (ref. 32) we
de novo assembled the individual genomes to an average N50 of
28 kbp and 12 kbp for scaffolds and scaftigs, respectively,
(stretches of non-N bases in the scaffolds; Supplementary
Fig. 5). We then aligned the assemblies to the reference genome
and after excluding the ambiguous alignments (misalignment
probability PZ0.01) the individual assemblies covered B95% of
the reference genome (Supplementary Fig. 6, Supplementary Data
4). We observed lower coverage of the assemblies over
interspersed repeats, TRs and segmental duplications33
(Supplementary Fig. 7, Supplementary Data 4). We identiﬁed
10Mbp of sequences (4100 bp) per individual that could not be
aligned to the human reference genome (total across 10 trios
20Mbp). Most of these sequences (95%) can be mapped to the
decoy sequence that contains alternative human assembly
sequences (patches to build 37, sequences from HuRef34 and
NA12878 alternate assemblies), human fosmid clones and
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Figure 2 | De novo events in the trios. (a) Allele balance of detected de novo SNVs (n¼ 730). Variants with low allele balance (o0.3) are considered to be
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rate in CpG sites. Orange: CpG mutations, turquoise: mutations at A or T site and magenta: non-CpG mutations at C or G site. Error bars represent s.e.m.
(c) Germline SNVs increase signiﬁcantly with paternal age. The blue line is a linear ﬁt to the age of the father at the child’s birth and germline SNVmutation
rate, and the error bars represent s.e.m. (d) Allele balance of detected de novo indels (n¼ 121). (e,f) The indel length distribution indicates that short
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represent s.e.m.
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Epstein–Barr virus sequence (Supplementary Fig. 8, Supplemen-
tary Data 5). The remaining 300 kbp can be mapped to other
human genomes (Supplementary Fig. 8). Of the unmapped
sequences, 1.2Mbp can be localized in the reference genome
using the chimp genome and ﬂanking sequences in the de novo
assemblies, most of which are deletions in terms of ancestral state
(Supplementary Fig. 9).
Population scale calling of SVs. We developed the Soap
Assembly Variation discovery pipeline (SoapAsmVar, see meth-
ods and Supplementary Fig. 10) and employed it to detect SVs in
the individual de novo assemblies. The identiﬁcation of the SVs
was performed at per individual level, combined to population
level and thoroughly ﬁltered (see methods). We identiﬁed a
variety of SVs (232k) including deletions (81.9k, Z10 bp),
insertions (92.9k, Z10 bp), multiple nucleotide polymorphisms
(52.6k), inversions (29) and translocations (5.2k; Fig. 3a,b). The
number of these events is only a fraction of the SNVs (232k
versus 8.3 million), but the number of base pairs affected by the
non-redundant set is 13.4Mb, almost two times the number of
SNVs, consistent with previous study of the HuRef de novo
assembly34. The number and length distribution of the insertions
and deletions are highly symmetric and is consistent with
previous studies of a few individual de novo assemblies20,34
(Fig. 3c). A substantial part of the SVs are previously unknown
using a 50% reciprocal overlap criteria (insertions: 78.5k, 84.5%
and deletions: 53.2k, 64.9%) and these variants were enriched in
10–200 bp for deletions and almost all length ranges of the
insertions. This enrichment was especially large for insertions of
length 20–300 bp of which 92.2% were novel (49.0k of 53.1k in
total) and to a lesser degree for deletions in this range (23.0k of
30.9k in total, 74.4%). The size spectrum corresponds to distinct
formation mechanisms and is symmetric between deletions and
insertions3 (Fig. 3d). Variants within 50–200 bp tend to be
associated with variable number of TRs (VNTR), while variants
of 300 and 6 kbp derive from transposable element insertions.
Most of the larger variants (41 kbp) are related to non-allelic
homologous recombination (NAHR) or non-homologous
recombination (NHR). As VNTR indels can be hard to
accurately call3 we benchmarked the VNTR calls by
investigating the Mendelian errors of this variant category. In
total 25.4% of the raw 25,363 VNTRs contained at least one
Mendelian error and 8.1% of them contained at least two
Mendelian errors prior to ﬁltration using other metrics. However
this was not different compared with the Mendelian error rate
among the other raw SoapAsmVar calls and displayed less
Mendelian conﬂicts compared with raw indel calls from GATK
(Supplementary Table 4).
We compared the SoapAsmVar variants to the variants called
by GATK and found that for very short indels (1–4 bp) 65% of
the GATK calls were also called by SoapAsmVar and that 50% of
SoapAsmVar indels in this range were called by GATK
(Supplementary Fig. 11). However, when increasing the length
of the variants to 50 bp the fraction of SoapAsmVar calls which
were also called by GATK declined to 38% for deletions and 25%
for insertions. The genotype concordance at the overlapping sites
was high ranging from 57.7 to 76.7% (Supplementary Fig. 11).
The difference in concordance between the call sets reﬂects the
difﬁculties in deﬁning complex variants in the human genome
and de novo assembly may represent a promising alternative
strategy for variant discovery35.
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Because of the high novelty of the SoapAsmVar callset and that
SoapAsmVar called 19 times more insertions (Z50 bp) and 4.5
times more deletions (Z50 bp) compared with GATK we
experimentally validated a subset of the novel variants (Table 2,
Supplementary Data 2). We observed an overall FDR of 7.3%
(5/68) of which the FDR was higher for deletions (17%) compared
with insertions (5%). When investigating the mechanism of
formation especially indels associated with NAHR had a high
FDR (22%), however, the assay was only successful for nine sites.
In general the success rate of performing the validation assays was
relatively low and only 68 of the 272 randomly selected variants
could be assayed (Supplementary Data 2). This was particular true
for the VNTR validation assays where we were unable to perform
any of them due to their repetitive structure (25 were randomly
selected)3. This emphasizes the difﬁculties caused by the sequence
context in correctly calling and assaying SVs and the FDR for
difﬁcult sites may therefore be higher than what we report.
Discussion
Constructing a national pan-genome requires a variant catalogue
as complete and as little biased against complex variants as
possible. We have shown that a strategy based on high depth
sequencing, local assembly and de novo assembly can identify
novel SNVs, indels and SVs with high accuracy as estimated from
Sanger sequence validation experiments. Identiﬁcation of indels
and SVs are critical to assess the full variability of individual
genomes, however, current methods are mainly based on
alignment of reads to a reference genome, which is not a very
powerful way of detecting large and complex variants.
Utilizing a population based de novo assembly approach such
as SoapAsmVar greatly facilitates the identiﬁcation of such
variants because the de novo-assembled sequences are much
longer (scaffold N50: 28 kb) and therefore easier to anchor using
sequence that ﬂank the variants. This is exempliﬁed by the
medium-sized insertions (20–300 bp) of which 92.2% of the
variants were novel. In contrast, only 6.4% of the SNVs that we
identify have not been reported previously, because previous
efforts have primarily targeted SNVs and to a lesser extent short
indels. Our approach is powerful for identifying a much wider set
of novel variants for short indels and particularly longer indels
and SVs. We have estimated a low FDR of the identiﬁed variants
but estimation of the sensitivity for the SVs will require longer
insert libraries or longer read lengths. As expected, adding more
individuals to the pan-genome will increase the number of
variants (Fig. 4). For indels, a high proportion of novel variants
are found in the ﬁrst individual, reﬂecting that even very common
SVs have not been previously identiﬁed. In contrast, novel SNVs
are mainly rare variants or variants that have an exclusively high
frequency in the Danish population.
Obtaining accurate de novo mutation rate estimates is a key
factor for understanding human evolution16. The estimation of
mutation rates is more challenging than the identiﬁcation of the
de novo mutations themselves as it requires an accurate
estimation of the fraction of the genome where the de novo
events could be observed (the denominator of the mutation rate
estimator). Using a novel probabilistic approach, which estimates
the effective number of genomic positions where we can call de
novo mutations, we estimate the rate for de novo SNV germline
mutations and make a more precise estimate of indel mutation
rates from direct sequencing. The differences from the previous
rate estimates9,18,28 are mainly caused by differences in the way
the denominators are calculated rather than differences in the
number of mutations per individuals that are found in the studies.
We estimate a rate that is higher than most previous estimates,
making it slightly closer to mutation rates estimated from
phylogenetic estimates. We also show that it is possible to ﬁnd
short de novo indels, which may play an important role in disease.
Identiﬁcation of all variants and their frequencies can facilitate
an increased understanding of population-speciﬁc disease sus-
ceptibility and will be important for advancing clinical and public
health genetics7,36. In addition, future efforts should be aimed at
building a true national pan-genome sequence that can replace or
augment the current reference genome for national sequencing
projects. This will require either longer reads or the use of long-
range mate pair libraries to produce long scaffolds, which can
improve gaps in the current reference genome.
Methodological developments in the analysis and representation
of sequence data will offer advantages as well as addressing challenges
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visualized data is the average of 1,000 random samples of the individual
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Table 2 | Sanger validation of novel SVs called by
SoapAsmVar.
Variant class FDR Sites
Structural variants
Novel SVs 0.07 68
By length (bp)
50–100 0.10 39
101–300 0.00 9
301–500 0.10 10
501–1,000 0.00 10
By type
DEL 0.17 12
INS 0.05 56
By mechanism
Unknown 0.04 25
NAHR 0.22 9
NHR 0.06 33
TEI 0.00 1
VNTR NA 0
DEL, deletion; FDR, false discovery rate; GATK, Genome Analysis Toolkit; INS, insertion; NA, not
applicable; NAHR, non-allelic homologous recombination; NHR, non-homologous
recombination; SV, structural variant; TEI, transposable element insertions; VNTR, variable
number of tandem repeats.
In total 68 novel variants were subjected to validation and the FDR was stratiﬁed by length, type
of indel and formation mechanism.
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such as storing of variant population frequencies and alternative
haplotypes within a reference possibly through a population sequence
graph. Population-wide de novo assembly will certainly be needed to
facilitate discovery of complex variants, and the vast range of SVs
identiﬁed in this project indicates their importance for our
understanding of the structure of the human genome.
Methods
Cohort selection. The 10 trios (mother–father–child) for the pilot study of the
Genome Denmark project were selected from the Copenhagen Family Bank21,22.
The Copenhagen Family Bank dates back to the 1970s and constitutes a reference
databank for linkage analysis as it archives sampled blood from families with
numerous children together with comprehensive information about phenotypic
traits. We selected the individuals as part of a pilot effort for a larger study using
the criteria that (1) the trio individuals are still alive, (2) individuals reside in the
Copenhagen area, (3) have provided informed consent for further participation and
(4) there was enough blood available for DNA extraction and library preparation.
After sequencing we discovered that individual 1006-01 was of half Greenlandic
ancestry. We decided to include the trio in the analysis due to the Danish–
Greenlandic history and number of individuals resident in Denmark that are of
Greenlandic decent. All participants provided informed consent and the study
protocol was reviewed and approved by The Danish National Committee on
Health Research Ethics ﬁle no: 1210920, submission numbers 36615 and 38259.
Library construction and sequencing. Library construction and sequencing was
performed by Illumina HiSeq 2000 following the manufacturer’s instruction. Base
calling was performed using CASAVA 1.7. For each individual, three small insert
size libraries were constructed and sequenced—180 bp (30 ), 500 bp (10 ) and
800 bp (10 ).
Chip genotyping. Among the 10 trios, three subjects did not have enough DNA
left for genotyping. For the remaining 27 subjects, HumanCoreExome BeadChips
were used on a HiScan system (Illumina, San Diego, CA, USA), and the genotypes
were called using GenomeStudio software (version 2011.1; Illumina). All subjects
had a high call rate (498%), and the familial relationship and the sex of the
subjects were conﬁrmed. SNPs with a low call rate (o98%) or deviation from
Hardy–Weinberg equilibrium (Po0.0001) were excluded.
Read trimming and correction. After initial quality control assessment with
FastQC version 0.10.1 (ref. 37), AdapterRemoval38 was used to trim the tails of the
reads if the Phred quality dropped o2. AdapterRemoval was also used to collapse
180 bp insert size libraries into longer single end reads.
Alignment-based assembly. All reads from the compendium of libraries were
mapped to the human reference genome build 37 supplemented with unlocalized
contigs and the decoy sequence using BWA-MEM; version 0.7.5a (ref. 39).
SAMtools version 0.1.19 (ref. 40) and Picard version 1.96 (http://picard.
sourceforge.net) were used to process the alignment ﬁles and to mark duplicate
reads. GATK version 2.7-2 (ref. 23) was used to reﬁne the alignments by
performing local indel realignment and subsequent base quality recalibration using
Mills_and_1000G_gold_standard indels and NCBI’s dbSNP (build 138) as known
variant sites. Duplicate marking and base recalibration was performed at lane level
BAMs. Local indel realignment was performed both for each individual lane as well
as after merging BAMs by sample.
Genotyping. The Base Quality Score Recalibrated BAM ﬁles of the 30 individuals
were used as input for multi-sample genotyping using the HaplotypeCaller
of the Genome Analysis Toolkit version 2.7.2 (ref. 23). The raw variants were
recalibrated using VariantQualityScoreRecalibration (VQSR) including HapMap,
Omnichip, 1000G phase 1 high conﬁdence variants and dbSNP138 using
arguments given by best practices by the Broad Institute41. Furthermore the
following annotations were used: QD, MQRankSum, ReadPosRankSum, FS
and DP as well as ‘--numBadVariants 5000’. The indels were recalibrated using
Mills and 1000G database5 using similar parameters as above except for
‘--maxGaussians 4 --numBadVariants 1000. The SNVs were ﬁltered at a truth-
sensitivity tranche of 99.5, whereas the indels were ﬁltered at 95.0. Genotype
concordance of the called genotypes to HumanCoreExome calls was performed
using PLINK42 removing sites with AT and CG alleles.
Site frequency spectrum and variation effect. Derived alleles were determined
from the Ensembl compara v71 EPO alignments using only high conﬁdence calls
and only bi-allelic sites with genotype calls for all individuals were used for the site
frequency spectrums. The SNVs and indels were annotated for their effect on the
proteins using variant effect predictor tool from Ensembl version 73 (ref. 43). To
identify LOF mutations we used only proteins consensus coding sequences24–26
and disregarded mutations if (a) the mutation was ﬁxed in the samples, (b) the
variant allele was the same as the ancestral state based on human-primate
alignments, (c) if the variant was in a non-canonical splice site or (d) the variant
occurred in the ﬁrst or last 5% of the gene. Filters b–d are similar to what was used
in refs 7,27. For indels, ancestral alleles were identiﬁed by extracting ±10 nt
around the indel and manual inspection of presence or absence of the indel in the
ancestral allele. Novel SNVs were determined from dbSNP138, and novel indels
were determined as not in dbSNP138, and not found in Mills and 1000G database5
or Database of Genomic Variants44 with 50% reciprocal overlap.
Indel repeat classiﬁcation. The sequence 100 bp upstream and downstream of
the outer indel coordinates were used as input to Tandem Repeat Finder (TRF)45
and repeat annotations spanning the indels were extracted. Indels were classiﬁed as
a canonical HR if the variant was within a run of six or more identical bases, as a
TR if the variant was within a segment of at least two repeated sequences41 bp. A
TR indel was annotated as canonical if the repeated segment was recurring at least
UnitLength 2þ 5 times, for example, a repeat segment of 2 bp must be repeated
at least 9 times, a repeat segment of 3 bp must be repeated at least 11 times and so
on4. Variants where the HR consisted of not only the HR base where classiﬁed as
non-canonical HR and variants where the TR did not fulﬁl the minimum repeated
number were classiﬁed as non-canonical TR. The VCF ﬁle contains the annotations
in the info ﬁeld as HR, TR, HR_NC and TR_NC.
Identiﬁcation of de novo SNV. We developed a new method for detecting de novo
mutations, where we incorporate sequencing depth as a variable and not as a strict
ﬁlter. To limit the number of false positives we only consider a Mendelian violation as
a possible de novomutation if both parents in the family in question are homozygotes
for the reference allele and if the variant is not called in any of the other families.
We apply the following ﬁlters when we look for de novo mutations:
(1) A site ﬁlter that looks at the reads from all 30 individuals to ﬁlter away bad
sites that are not true variants. The site ﬁlter uses the following tests:
a. FS: Fisher’s exact test on strand bias
b. ReadPosRankSum: rank sum test on position of the alternative allele in the
reads.
(2) Individual ﬁlters that look at the reads and genotype call of a single individual
to discard a possible de novo call if we are not sure that all of the individuals in
the family in question are called correctly. We use two different kinds of
Individual ﬁlters:
a. Homozygote reference ﬁlter. This ﬁlter is applied to the parents to check that
we have conﬁdence that they really are homozygous for the reference allele.
The ﬁlter uses the following parameters:
i. Genotype quality of the individual (GQ)
ii. Number of reads for this individuals at this site (DP)
iii. Number of times the alternative allele is seen in this individual (AD2)
b. Heterozygote ﬁlter: This ﬁlter is applied to the child to ensure that the child
really is heterozygous at this site. The ﬁlter uses the following parameters:
i. GQ
ii. DP
iii. AlleleBalance: the fraction of the reads in the individual that contains the
alternative allele.
Estimating callable sites for de novo mutations. To estimate the rate of de novo
mutations in a trio, we base the denominator of the rate estimate on the probability
at each site that we can call de novo mutation rather than simply counting a site as
either callable or non-callable. The probability of calling site x as a de novo
mutation given that it is a true de novo mutation in the family f we name the
callability and denote it by Cdenovof ðxÞ. The callability can be estimated indepen-
dently for each family based on the depth of the family members at the site, and the
expected number of callable sites in a given family is then the sum of the callability
of all sites in that family.
Since the site ﬁlter is based on statistical tests that follow a known distribution,
we can estimate how many good sites we expect to be ﬁltered away by this ﬁlter.
For this purpose we look at the null distribution of the tests and assume that the
two tests are independent. We denote by asite the fraction of good sites that we
expect to be ﬁltered away.
The mutation rate of a family f can then be estimated as:
ratef ¼ jde novo mutations in f after filtering j2 1 asiteð Þ
P
xEsites C
denovo
f ðxÞ
ð1Þ
Now let Z be a genotype (Hetero, HomRef or HomAlt) and consider for an
individual i the probability of calling it as Z at position x (and not ﬁltering it away)
given that the individual truly is Z at x. We denote this conditional probability by
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CZi ðxÞ and it signiﬁes the ability to give a true call of Z at x. Clearly this will be a
function of sequencing quality at x (not least the depth). If we assume that the
ability to truly call each member of a family is independent, then the callability of a
site in a given family can be calculated as the probability of calling each individual
correctly after ﬁltering:
Cdenovof ðxÞ ¼ CHeteroc ðxÞ  CHomRefp ðxÞ  CHomRefm ðxÞ ð2Þ
where c, p and m indicate the child, father and mother of the family f.
Assuming that CHeteroc xð Þ is independent of the parental genotypes as long as
they are conducive to a heterozygous offspring, we can estimate it by considering
only variants where one parent is homozygous reference with high conﬁdence and
the other parent is homozygous for the alternative allele. At such sites the child
should always be a heterozygote (barring de novo events). Using these sites only we
can estimate:
CHeteroc ðxÞ ¼
SHeterodðc;xÞ






SAlldðc;xÞ






ð3Þ
where d(c,x) is the depth at x for the child c and SAlld ¼ variant-familypairs
f 0; x0ð Þ where the child c0 has depth d(c,x)¼ d at variant x0 and one of the parents
is HomRef from the variant and the other parent is HomAlt after applying the sites
ﬁlter and a conservative ﬁlter on the genotype quality of the parents,
SHeterod ¼ the subset of SAlld where the child is called as heterozygous and passes
the heterozygote ﬁlter.
Similarly we can calculate:
CHomRefi ðxÞ ¼
MHomRefdðc;xÞ






MAlldðc;xÞ






ð4Þ
Where i is either m or p and MAlld ¼ variant-family pairs f 0; x0ð Þ where all the
children c0 have depth d(c,x)¼ d, and both parents in each family in question are
HomRef for the variant, the variant is present in at least one of the other families
after applying the sites ﬁlter and a conservative ﬁlter on the genotype quality of the
parents, and in the case of SNVs the variant must be in dbSNP,
MHomRefd ¼ thesubsetof MAlld where the children are called as homozygous for
the reference allele and pass the homozygote ﬁlter.
Supplementary Fig. 12 shows CHomRefi and C
Hetero
c (for the ﬁlter cutoffs
described in the next section).
Minimizing false-positive de novo mutation calls. While the estimation of
callability, as described above, reduces the effect of false negatives on the estimated
mutation rate, it is still necessary to set the cutoffs in the ﬁlters so high that only
very few or no false positives get into the set of estimated de novo mutations. We
can ﬁt the ﬁlter criteria by looking at the effect of different criteria on the rate
estimate and the effect on how large a fraction of the called de novo variants are
present in dbSNP (Supplementary Fig. 13).
Based on these considerations we set the ﬁlter values at:
 GQZ50 (for both the homozygote and heterozygote ﬁlter)
 DPA[10;120] (for both the homozygote and heterozygote ﬁlter)
 AD2¼ 0 (for the homozygote ﬁlter)
 Allele Balance A[0.3; 0.7]
The AlleleBalance ﬁlter was set based on the distribution of AlleleBalance in the
children after applying the other ﬁlters (see Fig. 2a).
De novo assembly of the individual genomes. We used the SoapDenovo2
package32 to de novo assemble each of the 30 individuals. The workﬂow included
(1) data ﬁltration where reads with440% low quality base or 10% N are removed.
(2) error correction where base and indel errors in a read are corrected. (3)
connection of 180 bp paired-read reads into 180 bp long reads to improve the gap
ﬁlling procedure. (4) PreGraph where a de Bruijn graph is constructed using
k¼ 45. (5) contig building where we remove tips and merge bubbles whenever the
difference between the two paths is o3 bp, resolve repeats in the de Bruijn graph
and output the consensus sequence. (6) mapping of the pair-end reads towards the
contigs to construct the linkage graph of the contigs sequences. (7) stepwise
scaffolding where the contigs that are unambiguously connected by more than ﬁve
reads are placed in the same scaffold and (8) gap ﬁlling where we perform local
assembly to iteratively ﬁll the gaps within the scaffolds using all the relevant reads.
Assembly-versus-assembly alignment. We applied the last aligner46 to align the
scaffolds to the human reference genome. Split alignment was performed to allow
for the existence of genome rearrangements. The misalignment probability was
computed providing the Phred-scale conﬁdence of the correctness of genome-scale
alignment and the base-scale alignments. In the ﬁnal assembly-versus-assembly
alignments, every non-overlapping DNA piece of the scaffold was anchored to a
unique position in the reference and we only kept alignments with misalignment
probabilities o0.01.
Assembly evaluation. We evaluated the individual assemblies using three metrics:
continuity, coverage and accuracy. For continuity, we computed the N10 to N90 of
the raw contig, scaffold and scaftigs. We also evaluated the proportions of Encode
18 gene and coding regions that could not be covered entirely by one continuous
scaffold. The coverage was calculated as the proportion of the bases in the reference
genome that were covered by the individual assembly after excluding alignment
ambiguity. The accuracy was empirically evaluated by the number of variants
(identiﬁed in the SVD module in the SoapAsmVar package as described below) that
did not obtain support from local realignment or from the short read alignments.
Variant discovery and genotyping based on de novo assemblies. We developed
the SoapAsmVar package to discover and genotype the variants from the indivi-
dual de novo assemblies. There are six modules: (1) structural variation detector
(SVD) module where we detect and characterize the SVs into ‘indels’, ‘deletions’,
‘insertions’, ‘multiple nucleotide polymorphisms’, ‘duplications’, ‘inversions’ and
‘translocations’ by enumerating the anomalous alignments between the individual
assembly and the reference. (2) align-gap-excise (AGE) module where we apply the
align-gap-excise algorithm47 to validate the variants and to reﬁne both the types
and the breakpoints of the variants identiﬁed in the SVD module. (3) SVVeriﬁed
module where we remove potential false-positive calls at which either no signiﬁcant
anomalous short-read-versus-reference alignments or excessive anomalous short-
read-versus-assembly alignments is observed. (4) genotype module where we ﬁrst
integrate all the variants from the population and genotype the variant in each
individual. For each variant locus, we ﬁt the normalized read depth of the proper
aligned reads around the variant loci into a linear constraint Gaussian model and
obtain the genotype likelihoods and Phred-scale genotype quality for all the three
genotype states. (5) de-duplicate module where we obtain the best alleles for a
polymorphic loci when individual assemblies emit different alleles for this loci. (6)
posterior treatment module is population based: We keep the variants for
downstream analysis that (1) are recurrently observed in more than one individual
assembly; (2) for which 50% of the individuals have genotype quality430; (3) for
which the InbreedingCoefﬁcient is 4 0.15; (4) do not violate Hardy–Weinberg
equilibrium with signiﬁcance threshold 0.001; (5) do not violate Mendelian
inheritance law.
Novel sequences analysis. We identiﬁed the assembled sequences that were
4100 bp and that cannot be aligned to the GRCh37 human genome sequence. We
realigned the sequences and obtained the novel sequences that were unambigu-
ously aligned to the decoy sequence in 1KGP project, YH assembly, African
assemblies and the Homo sapiens sequences in the NT database using either last46
or blastn48.
Formation mechanisms of the SVs. We applied the breakSeqv1.3 pipeline3 to
characterize the SVs that were 450 bp into four categories of mechanisms VNTR
(Variable number tandem repeat), NAHR (Non-Allelic Homolog Recombination),
TEI (Transposonable Element Insertions) and NHR (Non-Homologous
Recombination). The ancestral state of the polymorphic loci was determined by
comparisons of the reference allele, as well as the observed alternative allele with
the chimpanzee (panTro4), orangutan (ponAbe2) and macaque (rheMac3)
sequences in the syntenic regions of the corresponding net alignments. The allele
with identity and coverage 490% was determined as the ancestral state.
Validation of polymorphisms. We randomly selected 50 de novo SNVs, 50 de
novo indels, 49 LOF SNVs, 53 LOF indels, 50 novel SNVs, 50 novel indels and 272
novel SVs from SoapAsmVar (450 nt) covering different size and predicted for-
mation mechanism spectrums for experimental validation using Sanger sequen-
cing. All variants were selected from the 1298 trio and assayed in the father, mother
and child. Successfully ampliﬁed PCR amplicons was sequenced using a Sanger
AB3730xI DNA Analyzer and chromatograms were analyzed using PolyPhred 6.18
(ref. 49) to genotype SNVs and small indels. SVs were analyzed manually.
Hereafter all calls were manually inspected using Chromas 2.11, and we required
that the variant calls from the NGS pipeline had the exact same breakpoints to be
successfully validated.
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